Glucotrack (Nasdaq:GCTK) may be bringing its continuous blood glucose monitor (CBGM) technology to automated insulin delivery ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

Glucotrack’s Continuous Blood Glucose Monitor (CBGM) will provide real ... We are honored to join FORGETDIABETES to develop a fully implantable closed loop system for people living with diabetes.” ...

The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. This news release contains forward-looking statements within the ...

We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look ...

Analysts are estimating that Abbott Laboratories will report an earnings per share (EPS) of $1.07. The market awaits Abbott ...

Earlier on February 12 this year, Chief Investment Officer at Cetera Financial Group, Gene Goldman, discussed how he thinks ...

syste Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technologyRUTHERFORD, N.J., Feb. 26, 2025 (GLOBE ...

Q1 2025 Earnings Call Transcript April 16, 2025 Abbott Laboratories beats earnings expectations. Reported EPS is $1.09, ...

In particular, patients with type 1 DM exhibit poor glycemic control owing to an extreme impairment of glucose tolerance ... in a dental implant outpatient with type 1 DM. A case with impending ...

Seals survive pregnancy under extreme conditions. Their biology could improve IVF, diabetes care, and birth safety.